Heme oxygenase-1 is a predictive biomarker for therapeutic targeting of advanced clear cell renal cell carcinoma treated with sorafenib or sunitinib

BACKGROUND: We analyzed the expression of heme oxygenase-1 (HO-1) in patients undergoing radical nephrectomy for advanced clear cell renal cell carcinoma (CC-RCC) and evaluated the effects of the targeted therapies treated with sorafenib and sunitinib. METHODS: Expression of HO-1 in cancer tissue fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Wan-Xiang, Yan, Fei, Xue, Qin, Wu, Guo-Jun, Qin, Wei-Jun, Wang, Fu-Li, Qin, Jun, Tian, Chun-Juan, Yuan, Jian-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539079/
https://www.ncbi.nlm.nih.gov/pubmed/26309414
http://dx.doi.org/10.2147/OTT.S86222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539079/
https://www.ncbi.nlm.nih.gov/pubmed/26309414
http://dx.doi.org/10.2147/OTT.S86222

Ejemplares similares